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DURHAM, N.H. -- University of New Hampshire administrators and senior executive officers of
Bentley Pharmaceuticals, Inc. met recently to celebrate Bentley's first hire of a UNH graduate
and lay the groundwork for future collaboration. Materials scientist Zhengmao Li, Ph.D. '04 has
been named manager of protein/peptide delivery programs for the Exeter, N.H.-based company.
"It's a perfect fit," said Robert J. Gyurik, Bentley's vice president of pharmaceutical
development. "Zhengmao came to us fully formed, and he's already translating our needs into
new technology."
As a graduate student at UNH, Li studied intranasal
insulin delivery under materials science Professor Yvon
Durant—a project jointly sponsored by the university,
the New Hampshire Industrial Research Center, and
Bentley. "At UNH, students can build life-long
relationships with faculty who are conducting cuttingedge research," Li said.

From left to right, UNH President Ann Weaver
Hart, Zhengmao Li '04, and Bentley
Pharmaceuticals President James Murphy in
Bentley's Exeter, N.H. laboratory.

" We are delighted to celebrate Zhengmao's new
position and look forward to our ongoing partnership
with Bentley," UNH President Ann Weaver Hart said.
"The university is committed to the production of
knowledge that addresses scientific needs in today's
world, and one way we fulfill this mission is through
deep and reciprocal relationships such as the one we

recognize with Bentley."
" As a New Hampshire company, we appreciate that our state university can provide us with
outstanding resources," said James R. Murphy, chairman, president, and CEO for Bentley. The
company recently collaborated with UNH testing an intranasal spray as an alternative form of
insulin delivery.
A specialty pharmaceutical company focused on advanced drug delivery technologies and
pharmaceutical products, Bentley manufactures and markets a growing portfolio of generic and
branded pharmaceuticals in Europe through its subsidiaries in Spain. In May, the company,
which has 326 employees in Europe and the U.S., began trading on the New York Stock
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Exchange under the ticker symbol "BNT."
" At UNH, we don't create barriers between our research groups," said John Aber, vice president
for research and public service. "Our relationship with Bentley is an excellent example of the
kind of public-private partnership that UNH is creating. Our interaction with Bentley brings new
resources and energy to the process of discovery that is a core UNH mission."
" Bentley is the largest pharmaceutical company in New Hampshire," said Arthur Greenberg,
dean of the College of Engineering and Physical Sciences, "and we look forward to
collaborations that will partner the resources of the university, state-of-the-art instrumentation,
materials science, organic synthesis, and computational chemistry with this forward-looking
company."
" The biggest thing we can offer Bentley is the collaborations we provide," added UNH's
William Trumble, dean of the College of Life Sciences and Agriculture. "We have an
environment in which we can pull in areas of expertise—for example, our genomics center, the
use of robotics to develop chip technology, immunology, and endochrinomics." The college's
Center to Advance Molecular Interaction Science (CAMIS) serves the pharmaceutical,
biotechnology and materials science industries through the development of tools and techniques
to characterize and control the interaction of biological molecules
.
Members of the university party included President Ann Weaver Hart; John Aber, vice president
for research and public service; Arthur Greenberg, dean, College of Engineering and Physical
Science; William Trumble, dean, College of Life Sciences and Agriculture; Yvon Durant,
professor, materials science; Jerome Claverie, professor, materials science; Jennifer Goldberg,
associate director of major gifts, UNH Foundation, Inc.; and graduate student Floraine Collette,
who is involved with the research programs funded by Bentley Pharmaceuticals.
The Bentley group included James R. Murphy, chairman, president, and CEO; Robert J. Gyurik,
vice president, pharmaceutical development; James Hand, vice president, business development
and licensing; Michael D. Price, chief financial officer; Paul Fitzgibbons, director, program and
project management; Zhengmao Li, manager, protein/peptide development program; Carl
Reppucci, manager, formulation science; and Ivo Velazco, manager, product development.
A photo is available for download at: http://www.unh.edu/news/img/bentley.jpg
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